Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXIS 2: AX200 in Ischemic Stroke
NCT00927836Phase 2Completed
- Sponsor
- Sygnis
- Start
- May 2009
- Primary completion
- Nov 2011
- Modality
- Cytokines & Interferons
- Countries
- 7
01
Overview
A Phase 2 trial of filgrastim in ischemic stroke, sponsored by Sygnis. Started May 2009; status: completed.
02
Drugs
filgrastim
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00927836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927836.